The gut-brain-mitochondria axis redefines metabolic regulation, evolving our understanding from a binary appetite switch to a complex architecture of cellular quality control
When prescribed and monitored by our internal medicine specialists, tirzepatide can be a valuable part of a comprehensive weight management plan
Whitley HP, Trujillo JM, Neumiller JJ
doi: 10.1111/and.13975, 159
Insurance companies use PAs to restrict coverage to patients meeting narrow clinical thresholdstypically a BMI 30, or 27 with at least one weight-related comorbidity (such as hypertension, type 2 diabetes, or obstructive sleep apnea), combined with documented failure of previous lifestyle interventions
higher doses typically cause more pronounced gastrointestinal symptoms